A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma

Tejaswi V. Mudigonda, Kenneth Wyman, David R. Spigel, Kimberly B. Dahlman, F. Anthony Greco, Igor Puzanov, Mark C. Kelley, John D. Hainsworth, Jeffrey A. Sosman, Douglas B. Johnson*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma'. Together they form a unique fingerprint.